Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Operating Margin
Fisher & Paykel Healthcare Corporation Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| NZ |
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
20.8B NZD |
25%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228.6B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
185.1B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.3B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.6B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
115B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.8B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.1B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.9B USD |
29%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.3B USD |
32%
|
Fisher & Paykel Healthcare Corporation Ltd
Glance View
Nestled in the heart of New Zealand, Fisher & Paykel Healthcare Corporation Ltd. has emerged as a formidable player in the global healthcare market, largely due to its innovative spirit and relentless focus on respiratory care solutions. Originally part of Fisher & Paykel Industries, the healthcare division carved its own path in 2001, quickly becoming synonymous with high-quality medical devices. The company’s journey can be compared to a constant rhythm of innovation, particularly in areas that address obstructive sleep apnea, acute respiratory distress, and surgical humidification. Its revenue streams are primarily bolstered by a diverse array of products, including sleep apnea masks, humidifier systems for intensive care units, and related respiratory accessories. These offerings are not just technological marvels but are designed to improve patient outcomes and their quality of life, which resonates well with healthcare providers worldwide. Over the years, Fisher & Paykel Healthcare has strategically expanded its operations beyond its Kiwi roots, anchoring its presence in over 120 countries. This global footprint, coupled with a robust pipeline of patented products, enables sustained revenue growth and stability. The company’s financial health is driven by a business model that emphasizes research and development, ensuring that it remains at the forefront of medical innovation. By fostering close relationships with healthcare professionals and institutions, Fisher & Paykel not only gains invaluable insights to refine its products but also cultivates a loyal customer base. This enduring approach cements its position not only as a leader in the healthcare sector but also as a trusted partner in the critical mission to enhance patient care worldwide.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Fisher & Paykel Healthcare Corporation Ltd's most recent financial statements, the company has Operating Margin of 25.2%.
You don't have any saved screeners yet